Calpain Inhibition: A Therapeutic Strategy Targeting Multiple Disease States
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
615-638
Author(s):
N. O. Carragher
γ-Secretase as a Therapeutic Target for Treatment of Alzheimers Disease
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
661-670
Author(s):
Taisuke Tomita and Takeshi Iwatsubo
Fatty Acid Amide Hydrolase: A Potential Target for Next Generation Therapeutics
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
759-772
Author(s):
Mauro Maccarrone
A Partial Failure of Membrane Protein Turnover May Cause Alzheimers Disease: A New Hypothesis
Journal:
Current Alzheimer Research
Volume:
3
Page:
81-90
Author(s):
Kumar Sambamurti, Anitha Suram, Chitra Venugopal, Annamalai Prakasam, Yan Zhou, Debomoy K. Lahiri and Nigel H. Greig
Estrogen Receptors: Molecular Interactions, Virtual Screening and Future Prospects
Journal:
Current Topics in Medicinal Chemistry
Volume:
6
Page:
217-243
Author(s):
Andrew J.S. Knox, Mary J. Meegan and David G. Lloyd
The Role of Growth Factors in the Prevention and Treatment of Chemotherapy-Induced Peripheral Neurotoxicity
Journal:
Current Drug Safety
Volume:
1
Page:
35-42
Author(s):
Guido Cavaletti and Paola Marmiroli
Host Pharmacogenetics in the Treatment of HIV and Cancer
Journal:
Current Drug Safety
Volume:
1
Page:
107-116
Author(s):
Alan Winston, Eleftheria Hatzimichael, Vanessa Marvin, Justin Stebbing and Mark Bower
Current State of the Art of New Tubulin Inhibitors in the Clinic
Journal:
Current Clinical Pharmacology
Volume:
1
Page:
57-70
Author(s):
Isa E.L.M. Kuppens
Pharmacometrics of Stilbenes: Seguing Towards the Clinic
Journal:
Current Clinical Pharmacology
Volume:
1
Page:
81-101
Author(s):
Kathryn A. Roupe, Connie M. Remsberg, Jaime A. Yanez and Neal M. Davies
Clinical Pharmacology of Cyclophosphamide and Ifosfamide
Journal:
Current Drug Therapy
Volume:
1
Page:
55-84
Author(s):
Jing Zhang, Quan Tian and Shu-Feng Zhou